Home Cart Sign in  
Chemical Structure| 13063-04-2 Chemical Structure| 13063-04-2

Structure of Nitidine chloride
CAS No.: 13063-04-2

Chemical Structure| 13063-04-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Nitidine Chloride can inhibit proliferation and induce apoptosis via the Akt pathway, derived from genus Zanthoxylum.

Synonyms: Nitidine (chloride); NSC 146397

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Nitidine chloride

CAS No. :13063-04-2
Formula : C21H18ClNO4
M.W : 383.82
SMILES Code : C[N+]1=CC2=CC(OC)=C(OC)C=C2C(C=CC3=C4)=C1C3=CC5=C4OCO5.[Cl-]
Synonyms :
Nitidine (chloride); NSC 146397
MDL No. :MFCD01659688
InChI Key :QLDAACVSUMUMOR-UHFFFAOYSA-M
Pubchem ID :25659

Safety of Nitidine chloride

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Nitidine chloride

PI3K-AKT

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HeLa 1-10 µM 48 hours Inhibition of cancer cell proliferation PMC11929923
HCT116 1-10 µM 48 hours Inhibition of cancer cell proliferation PMC11929923
MDCK-hOCT2/hMATE1 cells 2.5 μM 120 minutes To evaluate the transcellular transport and intracellular accumulation of nitidine chloride in MDCK-hOCT2/hMATE1 cells, results showed that MATE1 plays a minor role in the transcellular transport of nitidine chloride PMC4959954
MDCK-hOCT2 cells 0.1 –4.0 μM 2 minutes To evaluate the uptake kinetics of nitidine chloride in MDCK-hOCT2 cells, results showed that nitidine chloride is a high-affinity substrate of hOCT2 with a Km of 0.97 ± 0.10 μM and Vmax of 288.1 ± 12.8 pmol·mg-1·protein·min-1 PMC4959954
Rat primary-cultured proximal tubular (rPCPT) cells 0.1 –50 μM 24 hours To evaluate the cytotoxicity of nitidine chloride in rat primary-cultured proximal tubular cells and the effect of OCT2 inhibitors, results showed that nitidine chloride concentration-dependently decreased cell viability, and OCT2 inhibitors significantly attenuated its toxicity PMC4959954
RAW 264.7 cells 1 μM, 10 μM 24 hours To evaluate the effect of NitC on LPS-induced inflammatory response. Results showed that NitC significantly inhibited the expression of iNOS, COX2, IL-1β, and NLRP3, indicating its ability to suppress NLRP3 inflammasome activation. PMC9353946
Cardiac fibroblasts (CFs) 1.25, 2.5, 5, 10, 20, 40 μM 24 or 48 hours To evaluate the effect of NC on cardiac fibroblasts, it was found that low concentrations of NC (1.25, 2.5, 5 μM) increased cell viability, while high concentrations (20, 40 μM) decreased cell viability PMC9388977
Li-7 hepatocellular carcinoma cells 10, 20, 40, 80 μg/mL 24, 48, 72 hours Evaluate the cytotoxic effect of TPGS-FA/NC on Li-7 cells, results showed TPGS-FA/NC had better cytotoxicity than 5-Fu and NC PMC9549606
HUVECs 10 μM 36 hours Nitidine chloride showed no significant effect on HUVECs PMC4310574
A549 cells 10 μM 36 hours Nitidine chloride significantly inhibited the dispersion of A549 cancer cells, almost completely abolishing the spheroids' dispersion PMC4310574
A549 0.5 μM 48 hours NC induced cell swelling and large bubbles emerging from the plasma membrane, showing typical pyroptotic features. PMC9524076
NCI-H1688 0.5 μM 48 hours NC induced cell swelling and large bubbles emerging from the plasma membrane, showing typical pyroptotic features. PMC9524076
MCF-7 cells 1 or 2.5 μM 48 hours NC inhibited the proliferation of MCF-7 cells in a dose-dependent manner and suppressed their migratory and invasive capabilities PMC4910241
MDA-MB-468 cells 1 or 2.5 μM 48 hours NC inhibited the proliferation of MDA-MB-468 cells in a dose-dependent manner and suppressed their migratory and invasive capabilities PMC4910241
U2OS cells 8 μM 48 hours To evaluate the effect of NC on U2OS cell apoptosis, results showed that NC treatment obviously induced cell apoptosis. PMC6389778
U2OS cells 4 μM 72 hours To evaluate the effect of NC on U2OS cell proliferation, results showed that NC significantly inhibited cell growth in a dose-dependent manner. PMC6389778
MG63 cells 1.5 μM 72 hours To evaluate the effect of NC on MG63 cell proliferation, results showed that NC significantly inhibited cell growth in a dose-dependent manner. PMC6389778

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Sprague-Dawley rats Healthy male rats Intravenous injection 5 mg/kg Once daily for 20 consecutive days To evaluate the nephrotoxicity of nitidine chloride in rats after 20 days of successive intravenous administration, results showed that nitidine chloride caused increased levels of blood urea nitrogen (BUN) and lactate dehydrogenase (LDH), reduced levels of alkaline phosphatase (ALP), and pathological changes in the kidney PMC4959954
C57BL/6 mice Cardiac hypertrophy model Intraperitoneal injection 2.5, 5, 10 mg/kg Once daily for 4 weeks To evaluate the effect of NC on cardiac function, it was found that high-dose NC caused cardiac hypertrophy and dysfunction in mice, and cardiac autophagy levels were reduced PMC9388977
BALB/c nude mice HCC xenograft model Intraperitoneal injection 7 mg/kg Every other day for 15 days Significantly reduced tumor volume PMC6737102
C57 mice High-fat diet-induced NAFLD model Gavage 8 mg/kg Once daily for 4 weeks To evaluate the therapeutic effect of NC-CS/PT-NPs on high-fat diet-induced NAFLD. Results showed that NC-CS/PT-NPs significantly inhibited weight gain, decreased serum AST, ALT and lipid levels, improved liver and intestinal inflammation, and altered the diversity of gut microbiota in mice. PMC10929648
Sprague-Dawley rats Chronic nephrotoxicity model Intravenous injection 2 mg/kg and 6 mg/kg Once daily for 21 days To evaluate the nephrotoxicity and underlying mechanisms of nitidine chloride. Results showed accumulation of NC in the inner cortex region of the kidney, leading to renal tubule damage and metabolic disturbances. PMC11314895
BALB/c mice H1688 or A549 xenograft model Intraperitoneal injection 8 mg/kg/week or 16 mg/kg/week Twice a week for 21 days NC significantly inhibited tumor growth and induced tumor cell pyroptosis by inhibiting the PI3K/Akt pathway. PMC9524076
Zebrafish HCC xenograft model Yolk sac injection 3.0 ng Every 24 hours To validate the inhibitory effect of NC on HCC growth, metastasis, and angiogenesis in vivo, results showed that NC significantly inhibited the growth, metastasis, and angiogenesis of HCC PMC11796242
BALB/c nude mice Liver cancer xenograft model Intraperitoneal injection 10, 5, 2.5 mg/kg Once daily for 14 days To evaluate the antitumor effect of nitidine chloride on liver cancer xenograft models, results showed that nitidine chloride significantly inhibited tumor growth PMC6192772
Sprague-Dawley rats Osteoarthritis model induced by destabilization of the medial meniscus (DMM) surgery Intra-articular injection 10 μM Once a week for 6 weeks To evaluate the effect of NitC on DMM surgery-induced osteoarthritis model. Results showed that NitC significantly alleviated cartilage erosion, ECM degradation, and subchondral alterations. PMC9353946

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.61mL

0.52mL

0.26mL

13.03mL

2.61mL

1.30mL

26.05mL

5.21mL

2.61mL

References

 

Historical Records

Categories